| Q34669165 | A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy |
| Q46876406 | A qualitative investigation of adherence to nutritional therapy in malnourished adult AIDS patients in Kenya |
| Q59798402 | Aging with HIV: what effect on mortality and loss to follow-up in the course of antiretroviral therapy? The IeDEA West Africa Cohort Collaboration |
| Q33661912 | Changes in serum phosphate and potassium and their effects on mortality in malnourished African HIV-infected adults starting antiretroviral therapy and given vitamins and minerals in lipid-based nutritional supplements: secondary analysis from the N |
| Q36447487 | Clinic-Based Food Assistance is Associated with Increased Medication Adherence among HIV-Infected Adults on Long-Term Antiretroviral Therapy in Zambia |
| Q45112147 | Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection |
| Q33617610 | Cost-effectiveness of community vegetable gardens for people living with HIV in Zimbabwe |
| Q36077885 | Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings |
| Q34056071 | Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia |
| Q46186937 | Effect of depressive symptoms and social support on weight and CD4 count increase at HIV clinic in Ethiopia |
| Q35678576 | Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection |
| Q52589311 | Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial. |
| Q33618988 | Effects of nutritional supplementation for HIV patients starting antiretroviral treatment: randomised controlled trial in Ethiopia |
| Q35111173 | Effects on anthropometry and appetite of vitamins and minerals given in lipid nutritional supplements for malnourished HIV-infected adults referred for antiretroviral therapy: results from the NUSTART randomized controlled trial. |
| Q35021189 | Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial |
| Q33624197 | Estimating the cost-effectiveness of nutrition supplementation for malnourished, HIV-infected adults starting antiretroviral therapy in a resource-constrained setting |
| Q37721892 | Evaluation of antiretroviral therapy (ART) provision in an early cohort of patients initiating ART in Ghana. |
| Q30245375 | From Wasting to Obesity: The Contribution of Nutritional Status to Immune Activation in HIV Infection |
| Q39820692 | Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment |
| Q40075047 | Impact of Moringa oleifera lam. Leaf powder supplementation versus nutritional counseling on the body mass index and immune response of HIV patients on antiretroviral therapy: a single-blind randomized control trial |
| Q35668434 | Increased systemic inflammation is associated with cardiac and vascular dysfunction over the first 12 weeks of antiretroviral therapy among undernourished, HIV-infected adults in Southern Africa. |
| Q41173471 | Lessons learned from the first wave of aging with HIV. |
| Q39100244 | Minimal impact of an iron-fortified lipid-based nutrient supplement on Hb and iron status: a randomised controlled trial in malnourished HIV-positive African adults starting antiretroviral therapy |
| Q28647212 | Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean |
| Q34157953 | Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects |
| Q26828045 | Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature |
| Q33750196 | Nutritional aspects of HIV-associated wasting in sub-Saharan Africa |
| Q43940315 | Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania |
| Q37261479 | Nutritional status of HIV-infected patients during the first year HAART in two West African cohorts. |
| Q37600844 | Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda |
| Q35697907 | Plasma Fatty Acids in Zambian Adults with HIV/AIDS: Relation to Dietary Intake and Cardiovascular Risk Factors |
| Q39124502 | Population-level decline in BMI and systolic blood pressure following mass HIV treatment: Evidence from rural KwaZulu-Natal |
| Q35110006 | Predictors of Weight Change in Male HIV-Positive Injection Drug Users Initiating Antiretroviral Therapy in Hanoi, Vietnam |
| Q90483414 | Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study |
| Q37282021 | Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria |
| Q36161797 | Risk factors for mortality among malnourished HIV-infected adults eligible for antiretroviral therapy |
| Q37168183 | Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa |
| Q33587556 | Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study |
| Q96299243 | Stigma and discrimination: barriers to the utilisation of a nutritional program in HIV care services in the Tigray region, Ethiopia |
| Q59806829 | The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality |
| Q53739294 | The economic benefits of high CD4 counts among people living with HIV/AIDS in Zambia. |
| Q35154032 | The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, Uganda |
| Q37883016 | The role of fecal elastase-1 in detecting exocrine pancreatic disease |
| Q30491997 | Underutilisation of routinely collected data in the HIV programme in Zambia: a review of quantitatively analysed peer-reviewed articles |
| Q36008473 | Very early anthropometric changes after antiretroviral therapy predict subsequent survival, in karonga, Malawi |
| Q40076712 | Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens |
| Q35974655 | Weight change after antiretroviral therapy and mortality |
| Q36840612 | Weight change at 1 mo of antiretroviral therapy and its association with subsequent mortality, morbidity, and CD4 T cell reconstitution in a Tanzanian HIV-infected adult cohort |
| Q91957393 | Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada |
| Q42871264 | Weight loss after the first year of stavudine-containing antiretroviral therapy and its association with lipoatrophy, virological failure, adherence and CD4 counts at primary health care level in Kigali, Rwanda |